€3.06 0.0 0.0%
Last Trade - 10:59am
| Market Cap | £13.9m |
| Enterprise Value | £13.9m |
| Revenue | £0.958k |
| Position in Universe | 940th / 1050 |
| Industry | Market | |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
| Year End 31st Dec | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020E | 2021E | CAGR / Avg | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.001 | 0.002 | 0.004 | 0.002 | 0.007 | 0.001 | -3.6% | ||||
| -87.3 | +845.7 | +2,701 | -32.8 | |||||||
|
x
|
||||||||||
| Profitability | ||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
| Cashflow | ||||||||||
| Dividends | ||||||||||
| Balance Sheet | ||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing % | |||
| Net Gearing % | |||
| Cash / Assets % |
| Liquidity (ttm) | ||
|---|---|---|
| Curr. Ratio | ||
| Quick Ratio | ||
| Interest Cov. | ||
| Efficiency (ttm) | ||
|---|---|---|
| Asset Turnover | ||
| Recs Turnover | ||
| Stock Turnover | ||
| Latest interim period vs. prior period | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
| 3yr Compound Annual Growth Rate | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
Revenue
Net Income
Normalised EPS
PE Ratio Range
Dividend Yield Range
|
Price Target:
( below Price)
|
31st Dec 2021
|
31st Dec 2022
|
||||
|---|---|---|---|---|---|---|
| Est. Long Term Growth Rate: |
Net Profit () |
EPS () |
DPS () |
Net Profit () |
EPS () |
DPS () |
| Consensus Estimate | ||||||
| 1m Change | ||||||
| 3m Change | ||||||
BMP Pharma Trading AG is a Germany-based holding company engaged in the international trade of pharmaceutical raw materials to pharmaceutical, health-food and nutraceutical industries. Its offers four types of pharmaceutical preparations: herbal and fruit extracts; narcotics, including pemoline, morphine monohydrate and others; food additives, such as L-carnitine, vinpocetine and others, and veterinary products. As of December 31, 2011, the Company's scope of consolidated encompassed B.M.P. Bulk Medicines & Pharmaceuticals GmbH, in which it held a 100%-stake, ALPHA Trading GmbH (100%-stake), B.M.P. Pharma Trading Corporation (100%-stake), and B.M.P. Biotec GmbH, in which the Company held a 51%-stake. Apart from B.M.P. Pharma Trading Corporation, which was based in Nashville in the United States, all subsidiaries were based in Germany.
| Last Annual | December 31st, 2019 |
| Last Interim | June 30th, 2020 |
| Public Since | April 21, 2004 |
| No. of Shareholders: | n/a |
| No. of Employees: | 35 |
| Sector | Healthcare |
| Industry | Pharmaceuticals |
| Index | |
| Exchange | Berlin Stock Exchange |
| Shares in Issue | 5,250,000 |
| Free Float | (0.0%) |
| Eligible for |
✓
ISAs
✓
SIPPs
|
| Address | Bornbarch 16, NORDERSTEDT, 22848, Germany |
| Web | http://www.bmp.ag/ |
| Phone | +49 40 6455680 |
| Contact | () |
| Auditors | ADKL AG |
As of 10:59am, shares in BMP Pharma Trading AG are trading at €3.06, giving the company a market capitalisation of £13.9m. This share price information is delayed by 15 minutes.
Shares in BMP Pharma Trading AG are currently trading at €3.06 and the price has moved by 0.197k% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the BMP Pharma Trading AG price has moved by 0.122k% over the past year.
There are no analysts currently covering BMP Pharma Trading AG.
BMP Pharma Trading AG is scheduled to issue upcoming financial results on the following dates:
BMP Pharma Trading AG does not currently pay a dividend.
BMP Pharma Trading AG does not currently pay a dividend.
BMP Pharma Trading AG does not currently pay a dividend.
To buy shares in BMP Pharma Trading AG you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
Shares in BMP Pharma Trading AG are currently trading at €3.06, giving the company a market capitalisation of £13.9m.
Here are the trading details for BMP Pharma Trading AG:
Based on an overall assessment of its quality, value and momentum, BMP Pharma Trading AG is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We were not able to load any forecast data for BMP Pharma Trading AG.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like BMP Pharma Trading AG. Over the past six months, the relative strength of its shares against the market has been 73.99%. At the current price of €3.06, shares in BMP Pharma Trading AG are trading at 0.133k% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The BMP Pharma Trading AG PE ratio based on its reported earnings over the past 12 months is 62.11. The shares are currently trading at €3.06.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
BMP Pharma Trading AG's management team is headed by:
Here are the top five shareholders of BMP Pharma Trading AG based on the size of their shareholding:
